Royal Biologics’ Cryo-Cord is the first non-dimethyl sulfoxide (DMSO)-free viable umbilical cord graft. The material is ideal for use in foot and ankle surgery. Cryo-Cord offers a new enhancement to traditional wound care therapies and is intended for use as a soft tissue barrier or wound dressing. It is processed using aseptic techniques and is frozen with a proprietary cryoprotectant. The company’s Autologous Live Cellular–based therapies offer surgeons an efficient and effective way to enhance surgical outcomes by providing alternatives to conventional therapies for bone and soft tissue–related injuries.